Corpus overview


MeSH Disease

Human Phenotype

Pneumonia (1)


There are no transmission terms in the subcorpus

    displaying 1 - 1 records in total 1
    records per page

    COVID-19: Beta-Thalassemia Subjects Immunised?

    Authors: Edouard Lansiaux; Philippe Pierre Pebay; Jean Laurent Picard; Joachim Son-Forget

    id:10.20944/preprints202004.0349.v1 Date: 2020-04-19 Source:

    The novel coronavirus pneumonia MESHD pneumonia HP (COVID-19) is a contagious acute respiratory infectious disease MESHD whose causative agent has been demonstrated to be a novel virus of the coronavirus family, SARSCoV-2. A recent pre-print study has showed a heme attack on the 1-beta chain of hemoglobin by COVID19. Beta-thalassemia MESHD results of a default in the hemoglobin beta- chain synthesis. 1,5% global population are heterozygotes for this disease. In this study, by a multiple linear regression, we have analyzed the evolution of COVID-19 infection MESHD in three Italian regions (Puglia, Sardinia, Sicilia) with different beta-thalassemic prevalences SERO, in order to search a link. The results have showed that betathalassemic heterozygote population prevalence SERO is correlated to immunity against COVID-19, by a regression. This paper is only for academic discussion, the hypotheses and conclusions needs to be confirmed by further research .

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.



MeSH Disease
Human Phenotype

Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.